Insurers balk at paying for Biogen’s $56,000-a-year Alzheimer’s treatment

November 22, 2021

U.S. health insurers say they want more proof before paying for Biogen Inc.’s Aduhelm, stalling sales of the costly new Alzheimer’s therapy that the company hailed as a breakthrough for patients.

Study details role of protein that may play a key role in the development of schizophrenia
Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and stability of myelin, suggesting an important impact on neurodegenerative diseases and mental disorders such as multiple sclerosis and schizophrenia. The findings pave the way for new research and potential treatments.
Study identifies new method for improving lung growth and function in preterm infants
Adding two weeks of continuous positive airway pressure for preterm infants in the hospital substantially improves lung growth and function, according to new research from Oregon Health & Science University.
Millions could lose no-cost preventive services if SCOTUS upholds ruling
A study by the Stanford Prevention Policy Modeling Lab (PPML) finds that almost 30% of privately insured individuals in the United States, or nearly 40 million people, use at least one of the free preventive health services guaranteed under the Affordable Care Act (ACA).
Cerebral palsy medications given to adults may not match needs
Pain and symptom management are important parts of caring for adults living with cerebral palsy.
Surprising findings about ADHD may help girls who are struggling
Researchers at NTNU have found new correlations between ADHD and anxiety, which are two major health issues among adolescents. The two disorders often co-occur in individuals, and recent findings now reveal that the relationship between them appears to be different in girls and boys.

Insurers balk at paying for Biogen’s $56,000-a-year Alzheimer’s treatment

Recent Posts

JUST IN